amiodarone has been researched along with losartan potassium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chang, PM; Ng, YY | 1 |
| Aghdam, KA; Grzybowski, A; Saari, JM; Wasinska-Borowiec, W | 1 |
1 review(s) available for amiodarone and losartan potassium
| Article | Year |
|---|---|
An Updated Review on the Most Common Agents Causing Toxic Optic Neuropathies.
Topics: Amiodarone; Erythropoietin; Ethambutol; Humans; Linezolid; Methanol; Optic Nerve Diseases; Phosphodiesterase 5 Inhibitors | 2017 |
2 other study(ies) available for amiodarone and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Amiodarone-induced hypothyroidism with EPO-resistant anemia in a patient with chronic renal failure.
Topics: Aged, 80 and over; Amiodarone; Anemia; Anti-Arrhythmia Agents; Drug Resistance; Erythropoietin; Humans; Hypothyroidism; Kidney Failure, Chronic; Male | 2008 |